Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir + Asunaprevir in treatment-naive HCV genotype 1b infection (China)
CTR20150462Phase 3Active
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daclatasvir, asunaprevir in chronic hepatitis C (CHC), sponsored by Bristol Myers Squibb. Started Jul 2015; status: active.
02
Drugs
daclatasvirasunaprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20150462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150462.